A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
NCT01873365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 448
Last updated 2018-06-01
Summary
The study aims to estimate the incidence of herpes zoster (HZ), proportion of postherpetic neuralgia (PHN) and the economic burden and impact on quality of life, in Japanese adults greater than or equal to sixty years of age.
Conditions
- Herpes Zoster
Interventions
- OTHER
-
Data collection
Case report forms (CRFs), logbooks and booklets.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-29
- Primary Completion
- 2015-02-04
- Completion
- 2015-02-04
Countries
- Japan
More Related Trials
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
NCT01827839 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster
NCT01327144 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
NCT01165203 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More
NCT06954818 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
NCT06569823 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Herpes Zoster: Risk Factors, Complications and Special Situations
NCT03903237 ·Status: COMPLETED
-
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
NCT05492591 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population.
NCT06207487 ·Status: NOT_YET_RECRUITING
-
Phase III Study of ASP2151 in Herpes Simplex Patients
NCT01959295 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
NCT00697567 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
NCT01915212 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers
NCT00711776 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults
NCT00698893 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
NCT00698568 ·Status: COMPLETED ·Phase: PHASE3
-
Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital
NCT01483378 ·Status: COMPLETED ·Phase: NA
-
A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
NCT05500053 ·Status: COMPLETED
-
Occlusion vs Standard Treatment for the Treatment of Herpes Zoster
NCT04258930 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems
NCT00002315 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster
NCT02151240 ·Status: COMPLETED ·Phase: PHASE4
-
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
NCT06903078 ·Status: RECRUITING
-
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
NCT00699764 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
NCT05298254 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open-label Study of ASP2151 in Herpes Simplex Patients
NCT02209324 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
NCT02412917 ·Status: TERMINATED ·Phase: PHASE3
-
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
NCT04950712 ·Status: COMPLETED